“Why has this new vaccine come and for what reasons?” key antecedents and questions for acceptance of a future maternal GBS vaccine: Perspectives of pregnant women, lactating women, and community members in Kenya

References

• Steer PJ, Russell AB, Kochhar S, Cox P, Plumb J, Gopal Rao G. Group B streptococcal disease in the mother and newborn—a review. Eur J Obstet Gynecol Reprod Biol. 2020;252:526–6. doi:10.1016/j.ejogrb.2020.06.024.
   PubMed Web of Science ®Google Scholar
• Armistead B, Oler E, Adams Waldorf K, Rajagopal L. The double life of group B streptococcus: asymptomatic colonizer and potent pathogen. J Mol Biol. 2019;431(16):2914–31. doi:10.1016/j.jmb.2019.01.035.
   PubMed Web of Science ®Google Scholar
• Group B streptococcus vaccine. [accessed 2023 Sep 14]. https://www.who.int/publications-detail-redirect/9789240037526.
   Google Scholar
• Seale AC, Koech AC, Sheppard AE, Barsosio HC, Langat J, Anyango E, Mwakio S, Mwarumba S, Morpeth SC, Anampiu K. et al. Maternal colonisation with streptococcus agalactiae, and associated stillbirth and neonatal disease in coastal Kenya. Nat Microbiol. 2016;1(7):16067. doi:10.1038/nmicrobiol.2016.67.
   PubMed Web of Science ®Google Scholar
• Paul P, Gonçalves BP, Le Doare K, Lawn JE. 20 million pregnant women with group B streptococcus carriage: consequences, challenges, and opportunities for prevention. Curr Opin Pediatr. 2023;35(2):223–30. doi:10.1097/MOP.0000000000001223.
   PubMed Web of Science ®Google Scholar
• Jisuvei SC, Osoti A, Njeri MA. Prevalence, antimicrobial susceptibility patterns, serotypes and risk factors for group B streptococcus rectovaginal isolates among pregnant women at Kenyatta National hospital, Kenya; a cross-sectional study. BMC Infect Dis. 2020;20(1):302. doi:10.1186/s12879-020-05035-1.
   PubMed Web of Science ®Google Scholar
• Le Doare K, O’Driscoll M, Turner K, Seedat F, Russell NJ, Seale AC, Heath PT, Lawn JE, Baker CJ, Bartlett L. et al. Intrapartum antibiotic chemoprophylaxis policies for the prevention of group B streptococcal disease worldwide: systematic review. Clin Infect Dis. 2017;65(Suppl 2):143–51. doi:10.1093/cid/cix654.
   PubMed Web of Science ®Google Scholar
• Verani JR, McGee L, Schrag SJ. 2010. Prevention of perinatal group B streptococcal disease: revised guidelines from CDC, 2010 [Internet]. Atlanta, Georgia: Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases; [accessed 2023 Nov 10]. https://www.cdc.gov/mmwr/preview/mmwrhtml/rr5910a1.htm.
   Google Scholar
• Giersing BK, Modjarrad K, Kaslow DC, Moorthy VS, Bavdekar A, Cichutek K, Cravioto A, Fritzell B, Graham BS, Karron R. et al. Report from the World Health Organization’s Product Development for Vaccines Advisory Committee (PDVAC) meeting, Geneva, 7–9th Sep 2015. Vaccine. 2016;34(26):2865–9. doi:10.1016/j.vaccine.2016.02.078.
   PubMed Web of Science ®Google Scholar
• Giersing BK, Vekemans J, Nava S, Kaslow DC, Moorthy V. Report from the World Health Organization’s third Product Development for Vaccines Advisory Committee (PDVAC) meeting, Geneva, 8–10 th June 2016. Vaccine. 2019;37(50):7315–27. doi:10.1016/j.vaccine.2016.10.090.
   PubMed Web of Science ®Google Scholar
• Defeating Meningitis by 2030. [accessed 2023 Sep 14]. https://www.who.int/initiatives/defeating-meningitis-by-2030.
   Google Scholar
• World health assembly endorses the 1st ever resolution on meningitis prevention and control. [accessed 2023 Sep 14]. https://www.who.int/news/item/13-01-2021-world-health-assembly-endorses-the-1st-ever-resolution-on-meningitis-prevention-and-control.
   Google Scholar
• Chander S, Gonzalez-Casanova I, Chaves SS, Otieno NA, Widdowson M-A, Verani J, Frew P, Wilson A, Omer SB, Malik F. Antenatal care providers’ attitudes and beliefs towards maternal vaccination in Kenya. Gates Open Res. 2021;4:19. doi:10.12688/gatesopenres.13091.2.
   PubMedGoogle Scholar
• KNBS and ICF. Kenya demographic and health survey 2022. Vol. 1. Nairobi, Kenya, and Rockville, Maryland, USA: KNBS and ICF; 2023.
   Google Scholar
• Chimbi J. 2023. Free maternal health care in Kenya “brought women and children back to hospitals.” Gavi VaccinesWork [Internet]. [accessed 2023 Nov 10]. https://www.gavi.org/vaccineswork/free-maternal-health-care-kenya-brought-women-and-children-back-hospitals.
   Google Scholar
• Nganga SW, Otieno NA, Adero M, Ouma D, Chaves SS, Verani JR, Widdowson M-A, Wilson A, Bergenfeld I, Andrews C. et al. Patient and provider perspectives on how trust influences maternal vaccine acceptance among pregnant women in Kenya. BMC Health Serv Res. 2019;19(1):747. doi:10.1186/s12913-019-4537-8.
   PubMed Web of Science ®Google Scholar
• Routine vaccines, in development. [accessed 2023 Sep 14]. https://www.gavi.org/vaccineswork/routine-vaccines-extraordinary-impact-group-b-streptococcus-gbs.
   Google Scholar
• WHO preferred product characteristics for group B streptococcus vaccines. [accessed 2023 Sep 14]. https://www.who.int/publications-detail-redirect/WHO-IVB-17.09.
   Google Scholar
• Giles ML, Buttery J, Davey M-A, Wallace E. Pregnant women’s knowledge and attitude to maternal vaccination including group B streptococcus and respiratory syncytial virus vaccines. Vaccine. 2019;37(44):6743–9. doi:10.1016/j.vaccine.2019.08.084.
   PubMed Web of Science ®Google Scholar
• Burns G, Plumb J. GBS public awareness, advocacy, and prevention—What’s working, what’s not and why we need a maternal GBS vaccine. Vaccine. 2013;31:D58–D65. doi:10.1016/j.vaccine.2013.02.039.
   PubMed Web of Science ®Google Scholar
• Dangor Z, Nunes MC, Kwatra G, Lala SG, Madhi SA. Vaccination of HIV-infected pregnant women: implications for protection of their young infants. Trop Dis Travel Med Vaccines. 2017;3(1):1. doi:10.1186/s40794-016-0044-7.
   PubMedGoogle Scholar
• Heyderman RS, Madhi SA, French N, Cutland C, Ngwira B, Kayambo D, Mboizi R, Koen A, Jose L, Olugbosi M. et al. Group B streptococcus vaccination in pregnant women with or without HIV in Africa: a non-randomised phase 2, open-label, multicentre trial. Lancet Infect Dis. 2016;16(5):546–55. doi:10.1016/S1473-3099(15)00484-3.
   PubMed Web of Science ®Google Scholar
• Krishnaswamy S, Wallace E, Buttery J, Giles M. Antenatal pertussis vaccination: Are we implementing best evidence into practice? Aust NZ J Obstet Gynaecol. 2016;56(6):552–5. doi:10.1111/ajo.12554.
   PubMed Web of Science ®Google Scholar
• Naidu MA, Krishnaswamy S, Wallace EM, Giles ML. Pregnant women’s attitudes toward antenatal pertussis vaccination. Aust NZ J Obstet Gynaecol. 2017;57(2):235–235. doi:10.1111/ajo.12615.
   PubMed Web of Science ®Google Scholar
• Krishnaswamy S, Lambach P, Giles ML. Key considerations for successful implementation of maternal immunization programs in low and middle income countries. Hum Vaccin Immunother. 2019;15(4):942–50. doi:10.1080/21645515.2018.1564433.
   PubMed Web of Science ®Google Scholar
• Pathirana J, Nkambule J, Black S. Determinants of maternal immunization in developing countries. Vaccine. 2015;33(26):2971–7. doi:10.1016/j.vaccine.2015.04.070.
   PubMed Web of Science ®Google Scholar
• Bergenfeld I, Nganga SW, Andrews CA, Fenimore VL, Otieno NA, Wilson AD, Chaves SS, Verani JR, Widdowson M-A, Wairimu WN. et al. Provider perspectives on demand creation for maternal vaccines in Kenya. Gates Open Res. 2018;2:34. doi:10.12688/gatesopenres.12833.1.
   PubMedGoogle Scholar
• Frew PM, Gonzalez-Casanova I, Otieno NA, Malik FA, Fenimore VL, Owino D, Adero MO, Atito RO, Bigogod G, Chaves SS. et al. Development of effective messages to promote maternal immunization in Kenya. Vaccine. 2022;40(27):3761–70. doi:10.1016/j.vaccine.2022.05.014.
   PubMed Web of Science ®Google Scholar